Feb. 03, 2010 - Issue #746: Spine
Well, Well, Well
Worth another look
One factor rarely causes a disease, and writing off co-factors is potentially dangerous
What I've said about vaccines and autism, contrary to what some have
understood, isn't that vaccines cause autism, but that many scientists and
researchers believe mercury to be a potential co-factor worth investigating
further.
It's very rarely any one thing that causes disease. Diseases, like car
accidents, happen when one too many contributing factors converge. Combine
unprecedented levels of new toxins with genetic predispositions, and disease
sets in. About half of us, says Dr. Mark Hyman, are missing a key
gene—GSTM1—which helps the body rebuild its stores of
glutathione, our last defense against toxicity. We are the ones who
haven’t yet evolved to deal with the new level of chemical
exposure.
When we haven’t yet found a cause for a disease, it's not
helpful—or scientific—to dismiss inconvenient facts. But malign
and dismiss is what we tend to do to those who propose new theories that
don’t line up with the existing wisdom in which we have invested much.
One of those very recently again misrepresented, in a January 17 Chicago
Tribune piece, is Dr. Boyd Haley.
The story, in short, is that a powerful antioxidant called OSR (Oxidative
Stress Relief), manufactured by Dr. Haley's biotech firm, CTI Science, has
been helping autistic children. CTI Science makes no claims for OSR’s
ability to treat disease or act as a chelator, though according to Haley,
anyone with knowledge of chemistry will know that it does have potent
antioxidant and chelation abilities. It raises glutathione levels, allowing
the body to maintain its natural detoxification processes. It has an
antioxidant capacity score many times higher than that of more commonly known
antioxidants such as blueberries, cranberries or garlic.
The families of autistic children have discovered OSR, and word has
spread.
What the Chicago Tribune reported is that OSR is an industrial chemical.
"It's technically true," Dr. Haley told me over the phone from Kentucky, "but
many chemicals have an industrial application. Production standards depend on
application, and they’re very stringent when the product is intended
for human consumption. We have to prove rigorous purification every time we
make a batch."
The Chicago Tribune also suggested that Haley has not been forthcoming with
the FDA. "We submitted a ton of pre-market safety data to the FDA," he says.
"We do nothing without clearing it with our lawyers, who are experts in FDA
regulations. The FDA knows everything about the product."
Is the product safe? "Animal studies with doses several thousand times higher
than would be given humans revealed no toxicities. It’s not mutagenic.
It doesn’t bind with essential minerals. The FDA approved it to test on
humans, which we did. We did blood and urine testing on 200 different
parameters. It elevated glutathione to healthy levels, and nobody’s had
an adverse reaction."
The Tribune article also implied dishonesty on the part of CTI Science around
the availability of OSR. The company’s website says it is available by
prescription; the Tribune was able to secure some without one. "Pharmacies
must sign an agreement to provide it only by prescription," Haley says. "The
Tribune was able to find a pharmacy willing to break that agreement. That
pharmacy is no longer selling it."
I can't help but wonder what purpose the tone of the Tribune article serves.
"It’s a scare tactic," Haley says. "It’s a way to come after the
doctors who treat these children being helped. We make no medical claims, but
everyone knows that reducing oxidative stress is a good thing to do.
Oxidative stress is another way of saying low glutathione levels."
It's easy to see why some may not particularly like Dr. Haley. He has
hypothesized that the mercury in vaccines is a significant contributing
factor to our alarming autism rates. And he's developed a compound that helps
autistic children, making the connection between mercury and autism more
difficult to dismiss. V
More stories in front »
New comments for this entry have been turned off and any existing ones are hidden. We apologize for any inconvenience.





